These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6794588)

  • 21. Valproic acid in epilepsy: clinical and pharmacological effects.
    Mattson RH; Cramer JA; Williamson PD; Novelly RA
    Ann Neurol; 1978 Jan; 3(1):20-5. PubMed ID: 350128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of valproic acid on hepatic functions.
    Maheshwari MC; Tandon RK
    J Assoc Physicians India; 1982 Aug; 30(8):529-31. PubMed ID: 6820370
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased fetal hemoglobin production in patients receiving valproic acid for epilepsy.
    Collins AF; Dover GJ; Luban NL
    Blood; 1994 Sep; 84(5):1690-1. PubMed ID: 7520784
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of diazepam and its metabolites on the binding of L-tryptophan to human serum albumen [proceedings].
    Ball HA; Davies JA; Nicholson AN
    Br J Pharmacol; 1979 May; 66(1):92P-93P. PubMed ID: 454973
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum protein binding of valproic acid and its displacement by palmitic acid in vitro.
    Monks A; Richens A
    Br J Clin Pharmacol; 1979 Aug; 8(2):187-9. PubMed ID: 385026
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum protein binding of diphenylhydantoin in man. II. Interaction with sodium valproate in epileptic patients.
    Gatti G; Lecchini S; Frigo GM; Visintini D; Calzetti S; Lombardi M; Cattaino G
    Farmaco Prat; 1979 Jan; 34(1):46-8. PubMed ID: 378689
    [No Abstract]   [Full Text] [Related]  

  • 28. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy.
    Dutta S; Faught E; Limdi NA
    J Clin Pharm Ther; 2007 Aug; 32(4):365-71. PubMed ID: 17635338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetic aspects of carbamazepine and valproic acid using in reproductive-age women with epilepsy].
    Karlov VA; Vlasov PN; Sokolov AV; Tishchenkova IF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(1):37-41. PubMed ID: 11842620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera. Role of uremic compounds.
    Dasgupta A; Jacques M
    Am J Clin Pathol; 1994 Mar; 101(3):349-53. PubMed ID: 8135194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anticonvulsant and neurotoxic effects of various combinations of phenobarbital, diazepam, sodium valproate, and 1,4-dihydropyridine ryodipine].
    Karpova MN; Kryzhanovskiĭ GN; Abrosimov IIu
    Biull Eksp Biol Med; 1994 Jul; 118(7):14-6. PubMed ID: 7919262
    [No Abstract]   [Full Text] [Related]  

  • 32. [Problems posed by the therapeutic combination of phenobarbital and sodium dipropylacetate. Apropos of a case].
    Millet Y; Sainty JM; Galland MC; Sidoine R; Jouglard J
    Eur J Toxicol Environ Hyg; 1976; 9(6):381-3. PubMed ID: 799967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R; Peters DH; McTavish D
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does sodium valproate increase clinical effects of diazepam? Double blind study.
    Vinar O; Dvorák A; Vinarová E; Fácková M; Pavlícek N; Tosnerová T; Husovská G
    Act Nerv Super (Praha); 1989 Jun; 31(2):106-7. PubMed ID: 2572129
    [No Abstract]   [Full Text] [Related]  

  • 35. The quantitative effect of serum albumin, serum urea, and valproic acid on unbound phenytoin concentrations in children.
    ter Heine R; van Maarseveen EM; van der Westerlaken MM; Braun KP; Koudijs SM; Berg MJ; Malingré MM
    J Child Neurol; 2014 Jun; 29(6):803-10. PubMed ID: 23670246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in cognitive functions in epileptics on sodium valproate monotherapy.
    Jha S; Nag D; Shukla R; Kar AM; Saxena RC; Trivedi JK
    Indian J Physiol Pharmacol; 1992 Apr; 36(2):135-6. PubMed ID: 1506080
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum protein binding of diphenylhydantoin in man. I. Interaction with sodium valproate.
    Lecchini S; Gatti G; De Bernardi M; Caravaggi M; Frigo GM; Calzetti S; Visintini D
    Farmaco Prat; 1978 Feb; 33(2):80-2. PubMed ID: 344060
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of epilepsy and valproic acid on oxidant status in children with idiopathic epilepsy.
    Yiş U; Seçkin E; Kurul SH; Kuralay F; Dirik E
    Epilepsy Res; 2009 Apr; 84(2-3):232-7. PubMed ID: 19261443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of several psychotic states with the combination of valproic acid with diazepam].
    Bourguignon A; Monfort JC; de Medeiros P; Cadet B; Chaneac D
    Ann Med Psychol (Paris); 1984 Nov; 142(9):1214-8. PubMed ID: 6442960
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neuroendocrine effects of a sodium valproate and diazepam combination in the male rat].
    Hariton C; Valli M; Courtière A; Mesdjian E; Baret A; Jadot G
    J Pharmacol; 1984; 15(2):137-42. PubMed ID: 6429450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.